India rejects Pfizer's patent application for its arthritis drug tofacitinib

India has reportedly rejected US drug-maker Pfizer's new patent application for rheumatoid arthritis drug, tofacitinib, for the second time.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news